Impact of BAFF Gene Polymorphisms on the Risk of Ulcerative Colitis and the Efficacy of Vedolizumab.
Clinical trial NCT07564895 · COMPLETED
Trial details
- NCT number
- NCT07564895
- Sponsor
- Second Affiliated Hospital of Wenzhou Medical University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-03-01
- Primary completion
- 2025-06-30
- Enrollment
- 841
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.